Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangyang Houbitong
- Development stage
- Unknown
- Lead developer
- Guizhou Bailing Group Pharmaceutical
- Administration
- Oral
01
Overview
Shuangyang Houbitong is a Traditional Chinese Medicine (TCM) formulation primarily developed and manufactured by Guizhou Bailing Enterprise Group. It is indicated for the treatment of acute pharyngitis and acute tonsillitis, characterized by symptoms such as sore throat, fever, and cough. The formulation typically contains ingredients like Rhizoma Belamcandae (Shegan), Cornu Naemorhedi (Goat Horn), and Rhizoma Dioscoreae Nipponicae (Chuanshanlong). Its therapeutic effects are attributed to its ability to clear heat, detoxify, and relieve swelling and pain in the throat. As a proprietary Chinese patent medicine, it is widely used in clinical practice in China for upper respiratory inflammatory conditions.
- Brand names
- Shuangyang Houbitong
- Other names
- Shuangyang Houbitong GranulesShuangyang Houbitong Keli
02
Targets
GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Shuangyang Houbitong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuangyang Houbitong.